HOSPITAL UNIVERSITARIO RUBER
Department
Rafael
López Zorzano
Publications by the researcher in collaboration with Rafael López Zorzano (2)
2018
-
Paclitaxel with inhibitor of apoptosis antagonist, LCL161, for localized triple-negative breast cancer, prospectively stratified by gene signature in a biomarker-driven neoadjuvant trial
Journal of Clinical Oncology, Vol. 36, Núm. 31, pp. 3126-3133